Tuberculosis infection in foreign-born children: a screening survey based on skin and blood testing

M Losi1, B M Bergamini, C Venturelli

  • 1Section of Respiratory Diseases, Department of Oncology, Haematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy. monica.losi@unimore.it

Insights

This study evaluated the QuantiFERON®-TB Gold In-Tube blood test for diagnosing latent tuberculosis infection (LTBI) in foreign-born children. The findings reveal both benefits and drawbacks of using this assay in a two-step diagnostic approach.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Pediatrics

Background:

  • Tuberculosis (TB) remains a global health concern, particularly in high-prevalence countries.
  • Immigration from high TB prevalence regions necessitates effective screening strategies in low-prevalence countries.
  • Accurate diagnosis of latent TB infection (LTBI) is crucial for preventing active disease progression.

Purpose of the Study:

  • To assess the utility of the QuantiFERON®-TB Gold In-Tube (QFT-GIT) assay for diagnosing LTBI in foreign-born children.
  • To evaluate the performance of QFT-GIT within a 'two-step' diagnostic strategy.
  • To identify potential advantages and concerns associated with using QFT-GIT in this specific pediatric population.

Main Methods:

  • The study involved foreign-born children residing in a low TB prevalence country.
  • The QuantiFERON®-TB Gold In-Tube assay was employed for LTBI diagnosis.
  • A 'two-step' diagnostic strategy incorporating the QFT-GIT was implemented.

Main Results:

  • The QFT-GIT assay demonstrated potential for diagnosing LTBI in foreign-born children.
  • Specific advantages of using the QFT-GIT in this cohort were identified.
  • Certain concerns or limitations regarding the QFT-GIT's application were also highlighted.

Conclusions:

  • The QFT-GIT assay can be a valuable tool for LTBI screening in foreign-born children.
  • Careful consideration of the assay's advantages and concerns is necessary for optimal implementation.
  • Further research may be warranted to refine the use of blood tests in diagnosing LTBI in pediatric immigrant populations.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...